Copyright Reports & Markets. All rights reserved.

Global and United States Cancer Testing Kits Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cancer Testing Kits Product Introduction
    • 1.2 Global Cancer Testing Kits Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Cancer Testing Kits Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Cancer Testing Kits Sales in Volume for the Year 2017-2028
    • 1.3 United States Cancer Testing Kits Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Cancer Testing Kits Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Cancer Testing Kits Sales in Volume for the Year 2017-2028
    • 1.4 Cancer Testing Kits Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Cancer Testing Kits in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Cancer Testing Kits Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Cancer Testing Kits Market Dynamics
      • 1.5.1 Cancer Testing Kits Industry Trends
      • 1.5.2 Cancer Testing Kits Market Drivers
      • 1.5.3 Cancer Testing Kits Market Challenges
      • 1.5.4 Cancer Testing Kits Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Cancer Testing Kits Market Segment by Type
      • 2.1.1 FIT Test
      • 2.1.2 HPV Test
      • 2.1.3 PSA Test
      • 2.1.4 AFP Test
      • 2.1.5 CEA Test
      • 2.1.6 Others
    • 2.2 Global Cancer Testing Kits Market Size by Type
      • 2.2.1 Global Cancer Testing Kits Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Cancer Testing Kits Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Cancer Testing Kits Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Cancer Testing Kits Market Size by Type
      • 2.3.1 United States Cancer Testing Kits Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Cancer Testing Kits Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Cancer Testing Kits Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Cancer Testing Kits Market Segment by Application
      • 3.1.1 Colorectal Cancer
      • 3.1.2 Breast Cancer
      • 3.1.3 Lung Cancer
      • 3.1.4 Ovarian Cancer
      • 3.1.5 Prostate Cancer
      • 3.1.6 Others
    • 3.2 Global Cancer Testing Kits Market Size by Application
      • 3.2.1 Global Cancer Testing Kits Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Cancer Testing Kits Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Cancer Testing Kits Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Cancer Testing Kits Market Size by Application
      • 3.3.1 United States Cancer Testing Kits Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Cancer Testing Kits Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Cancer Testing Kits Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Cancer Testing Kits Competitor Landscape by Company

    • 4.1 Global Cancer Testing Kits Market Size by Company
      • 4.1.1 Top Global Cancer Testing Kits Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Cancer Testing Kits Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Cancer Testing Kits Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Cancer Testing Kits Price by Manufacturer (2017-2022)
    • 4.2 Global Cancer Testing Kits Concentration Ratio (CR)
      • 4.2.1 Cancer Testing Kits Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cancer Testing Kits in 2021
      • 4.2.3 Global Cancer Testing Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Cancer Testing Kits Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Cancer Testing Kits Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Cancer Testing Kits Product Type
      • 4.3.3 Date of International Manufacturers Enter into Cancer Testing Kits Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Cancer Testing Kits Market Size by Company
      • 4.5.1 Top Cancer Testing Kits Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Cancer Testing Kits Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Cancer Testing Kits Sales by Players (2020, 2021 & 2022)

    5 Global Cancer Testing Kits Market Size by Region

    • 5.1 Global Cancer Testing Kits Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Cancer Testing Kits Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Cancer Testing Kits Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Cancer Testing Kits Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Cancer Testing Kits Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Cancer Testing Kits Sales in Value by Region: 2017-2022
      • 5.3.2 Global Cancer Testing Kits Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Cancer Testing Kits Market Size YoY Growth 2017-2028
      • 6.1.2 North America Cancer Testing Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Cancer Testing Kits Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Cancer Testing Kits Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Cancer Testing Kits Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Cancer Testing Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Cancer Testing Kits Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Cancer Testing Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Cancer Testing Kits Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Cancer Testing Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Abbott
      • 7.1.1 Abbott Corporation Information
      • 7.1.2 Abbott Description and Business Overview
      • 7.1.3 Abbott Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Abbott Cancer Testing Kits Products Offered
      • 7.1.5 Abbott Recent Development
    • 7.2 AB ANALITICA
      • 7.2.1 AB ANALITICA Corporation Information
      • 7.2.2 AB ANALITICA Description and Business Overview
      • 7.2.3 AB ANALITICA Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 AB ANALITICA Cancer Testing Kits Products Offered
      • 7.2.5 AB ANALITICA Recent Development
    • 7.3 Boditech Med
      • 7.3.1 Boditech Med Corporation Information
      • 7.3.2 Boditech Med Description and Business Overview
      • 7.3.3 Boditech Med Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Boditech Med Cancer Testing Kits Products Offered
      • 7.3.5 Boditech Med Recent Development
    • 7.4 LetsGetChecked
      • 7.4.1 LetsGetChecked Corporation Information
      • 7.4.2 LetsGetChecked Description and Business Overview
      • 7.4.3 LetsGetChecked Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 LetsGetChecked Cancer Testing Kits Products Offered
      • 7.4.5 LetsGetChecked Recent Development
    • 7.5 Everlywell
      • 7.5.1 Everlywell Corporation Information
      • 7.5.2 Everlywell Description and Business Overview
      • 7.5.3 Everlywell Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Everlywell Cancer Testing Kits Products Offered
      • 7.5.5 Everlywell Recent Development
    • 7.6 Pinnacle Biolabs
      • 7.6.1 Pinnacle Biolabs Corporation Information
      • 7.6.2 Pinnacle Biolabs Description and Business Overview
      • 7.6.3 Pinnacle Biolabs Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Pinnacle Biolabs Cancer Testing Kits Products Offered
      • 7.6.5 Pinnacle Biolabs Recent Development
    • 7.7 IDL Biotech
      • 7.7.1 IDL Biotech Corporation Information
      • 7.7.2 IDL Biotech Description and Business Overview
      • 7.7.3 IDL Biotech Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 IDL Biotech Cancer Testing Kits Products Offered
      • 7.7.5 IDL Biotech Recent Development
    • 7.8 Quidel Corporation
      • 7.8.1 Quidel Corporation Corporation Information
      • 7.8.2 Quidel Corporation Description and Business Overview
      • 7.8.3 Quidel Corporation Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Quidel Corporation Cancer Testing Kits Products Offered
      • 7.8.5 Quidel Corporation Recent Development
    • 7.9 Osang Healthcare
      • 7.9.1 Osang Healthcare Corporation Information
      • 7.9.2 Osang Healthcare Description and Business Overview
      • 7.9.3 Osang Healthcare Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Osang Healthcare Cancer Testing Kits Products Offered
      • 7.9.5 Osang Healthcare Recent Development
    • 7.10 Gencurix
      • 7.10.1 Gencurix Corporation Information
      • 7.10.2 Gencurix Description and Business Overview
      • 7.10.3 Gencurix Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Gencurix Cancer Testing Kits Products Offered
      • 7.10.5 Gencurix Recent Development
    • 7.11 Eurolyser Diagnostica
      • 7.11.1 Eurolyser Diagnostica Corporation Information
      • 7.11.2 Eurolyser Diagnostica Description and Business Overview
      • 7.11.3 Eurolyser Diagnostica Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 Eurolyser Diagnostica Cancer Testing Kits Products Offered
      • 7.11.5 Eurolyser Diagnostica Recent Development
    • 7.12 iDNA
      • 7.12.1 iDNA Corporation Information
      • 7.12.2 iDNA Description and Business Overview
      • 7.12.3 iDNA Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 iDNA Products Offered
      • 7.12.5 iDNA Recent Development
    • 7.13 GRAIL
      • 7.13.1 GRAIL Corporation Information
      • 7.13.2 GRAIL Description and Business Overview
      • 7.13.3 GRAIL Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 GRAIL Products Offered
      • 7.13.5 GRAIL Recent Development
    • 7.14 imaware
      • 7.14.1 imaware Corporation Information
      • 7.14.2 imaware Description and Business Overview
      • 7.14.3 imaware Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 imaware Products Offered
      • 7.14.5 imaware Recent Development
    • 7.15 Check4Cancer
      • 7.15.1 Check4Cancer Corporation Information
      • 7.15.2 Check4Cancer Description and Business Overview
      • 7.15.3 Check4Cancer Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.15.4 Check4Cancer Products Offered
      • 7.15.5 Check4Cancer Recent Development
    • 7.16 Labcorp
      • 7.16.1 Labcorp Corporation Information
      • 7.16.2 Labcorp Description and Business Overview
      • 7.16.3 Labcorp Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.16.4 Labcorp Products Offered
      • 7.16.5 Labcorp Recent Development
    • 7.17 Cologuard
      • 7.17.1 Cologuard Corporation Information
      • 7.17.2 Cologuard Description and Business Overview
      • 7.17.3 Cologuard Cancer Testing Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.17.4 Cologuard Products Offered
      • 7.17.5 Cologuard Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Cancer Testing Kits Industry Chain Analysis
    • 8.2 Cancer Testing Kits Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Cancer Testing Kits Distributors
    • 8.3 Cancer Testing Kits Production Mode & Process
    • 8.4 Cancer Testing Kits Sales and Marketing
      • 8.4.1 Cancer Testing Kits Sales Channels
      • 8.4.2 Cancer Testing Kits Distributors
    • 8.5 Cancer Testing Kits Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Cancer is the leading cause of death. Cancer symptoms can be subtle, and many go undetected until the cancer is in an advanced stage.However, a person can take steps to help prevent cancer and catch it early. Screenings and early detection can increase a person’s chance of receiving successful treatment and making a recovery.

      Cancer test kits help detect and screen for cancers in their early, more treatable stage, sometimes before a person shows any symptoms.
      Market Analysis and Insights: Global and United States Cancer Testing Kits Market
      This report focuses on global and United States Cancer Testing Kits market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Cancer Testing Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, FIT Test accounting for % of the Cancer Testing Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Colorectal Cancer was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Cancer Testing Kits market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Cancer Testing Kits Scope and Market Size
      Cancer Testing Kits market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cancer Testing Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Cancer Testing Kits market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Cancer Testing Kits market is segmented into
      FIT Test
      HPV Test
      PSA Test
      AFP Test
      CEA Test
      Others
      Segment by Application, the Cancer Testing Kits market is segmented into
      Colorectal Cancer
      Breast Cancer
      Lung Cancer
      Ovarian Cancer
      Prostate Cancer
      Others
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Cancer Testing Kits Market Share Analysis
      Cancer Testing Kits market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Testing Kits business, the date to enter into the Cancer Testing Kits market, Cancer Testing Kits product introduction, recent developments, etc.
      The major vendors covered:
      Abbott
      AB ANALITICA
      Boditech Med
      LetsGetChecked
      Everlywell
      Pinnacle Biolabs
      IDL Biotech
      Quidel Corporation
      Osang Healthcare
      Gencurix
      Eurolyser Diagnostica
      iDNA
      GRAIL
      imaware
      Check4Cancer
      Labcorp
      Cologuard
      Buy now